The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Cancer epigenetics: Moving forward
Open accessAbstract
Defects in chromatin modifiers and remodelers have been described both for hematological and solid malignancies, corroborating and strengthening the role of epigenetic aberrations in the etiology of cancer. Furthermore, epigenetic marks-DNA methylation, histone modifications, chromatin remodeling, and microRNA-can be considered potential markers of cancer development and progression. Here, we review whether altered epigenetic landscapes are merely a consequence of chromatin modifier/remodeler aberrations or a hallmark of cancer etiology. We critically evaluate current knowledge on causal epigenetic aberrations and examine to what extent the prioritization of (epi)genetic deregulations can be assessed in cancer as some type of genetic lesion characterizing solid cancer progression. We also discuss the multiple challenges in developing compounds targeting epigenetic enzymes (named epidrugs) for epigenetic-based therapies. The implementation of acquired knowledge of epigenetic biomarkers for patient stratification, together with the development of next-generation epidrugs and predictive models, will take our understanding and use of cancer epigenetics in diagnosis, prognosis, and treatment of cancer patients to a new level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
Kriaucionis, S., & Heintz, N. (2009) · Science · doi:10.1126/science.1169786 · Cited by 2,700
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Graves, A. P., III, A. D. P., Diaz, E., et al. (2012) · Nature · doi:10.1038/nature11606 · Cited by 1,786
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells
Ramsköld, D., Luo, S., Wang, Y.-C., Li, R., Deng, Q., Faridani, O. R., Daniels, G. A., Khrebtukova, I., Loring, J. F., Laurent, L. C., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2282 · Cited by 1,609
Epigenetic plasticity and the hallmarks of cancer
Flavahan, W. A., Gaskell, E., & Bernstein, B. E. (2017) · Science · doi:10.1126/science.aal2380 · Cited by 1,340
Adams, S., Gray, R. J., Demaria, S., Goldstein, L., Perez, E. A., Shulman, L. N., Martino, S., Wang, M., Jones, V. E., Saphner, T. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0491 · Cited by 1,299
SWI/SNF nucleosome remodellers and cancer
Wilson, B. G., & Roberts, C. W. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3068 · Cited by 1,282
Single-cell sequencing-based technologies will revolutionize whole-organism science
Shapiro, E., Biezuner, T., & Linnarsson, S. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3542 · Cited by 1,177
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
You, J. S., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.008 · Cited by 1,167
Canalization of Development and Genetic Assimilation of Acquired Characters
WADDINGTON, C. H. (1959) · Nature · doi:10.1038/1831654a0 · Cited by 1,094
Waddington, C. H. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr184 · Cited by 1,082
Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells
Carey, B. W., Finley, L. W. S., Cross, J. R., Allis, C. D., & Thompson, C. B. (2015) · Nature · doi:10.1038/nature13981 · Cited by 1,007
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S.-F., Dunning, M. J., Barbosa-Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-10-r214 · Cited by 948
A physical map of the human genome
The International Human Genome Mapping Consortium, Washington University School of Medicine, G. S. C., McPherson, J. D., Marra, M., Hillier, L., Waterston, R. H., Chinwalla, A., Wallis, J., Sekhon, M., Wylie, K., et al. (2001) · Nature · doi:10.1038/35057157 · Cited by 925
Interplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 910
Knutson, S. K., Warholic, N. M., Wigle, T. J., Klaus, C. R., Allain, C. J., Raimondi, A., Porter Scott, M., Chesworth, R., Moyer, M. P., Copeland, R. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303800110 · Cited by 789
The key to development: interpreting the histone code?
Margueron, R., Trojer, P., & Reinberg, D. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.01.005 · Cited by 749
Chromatin structure and the inheritance of epigenetic information
Margueron, R., & Reinberg, D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2752 · Cited by 742
Simon, J. A., & Kingston, R. E. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.013 · Cited by 733
Prediction of individual genetic risk to disease from genome-wide association studies
Wray, N. R., Goddard, M. E., & Visscher, P. M. (2007) · Genome Research · doi:10.1101/gr.6665407 · Cited by 725
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
Plitas, G., Konopacki, C., Wu, K., Bos, P. D., Morrow, M., Putintseva, E. V., Chudakov, D. M., & Rudensky, A. Y. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.032 · Cited by 695
De Simone, M., Arrigoni, A., Rossetti, G., Gruarin, P., Ranzani, V., Politano, C., Bonnal, R. J. P., Provasi, E., Sarnicola, M. L., Panzeri, I., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.021 · Cited by 687
ALKBH1-Mediated tRNA Demethylation Regulates Translation
Liu, F., Clark, W., Luo, G., Wang, X., Fu, Y., Wei, J., Wang, X., Hao, Z., Dai, Q., Zheng, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.038 · Cited by 584
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
Kulis, M., Heath, S., Bibikova, M., Queirós, A. C., Navarro, A., Clot, G., Martínez-Trillos, A., Castellano, G., Brun-Heath, I., Pinyol, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2443 · Cited by 578
Johann, P. D., Erkek, S., Zapatka, M., Kerl, K., Buchhalter, I., Hovestadt, V., Jones, D. T. W., Sturm, D., Hermann, C., Segura Wang, M., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.001 · Cited by 571
Epigenetic balance of gene expression by Polycomb and COMPASS families
Piunti, A., & Shilatifard, A. (2016) · Science · doi:10.1126/science.aad9780 · Cited by 524
Immune suppressive mechanisms in the tumor microenvironment
Munn, D. H., & Bronte, V. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.10.009 · Cited by 519
Elsheikh, S. E., Green, A. R., Rakha, E. A., Powe, D. G., Ahmed, R. A., Collins, H. M., Soria, D., Garibaldi, J. M., Paish, C. E., Ammar, A. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3907 · Cited by 511
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
Stunnenberg, H. G., Abrignani, S., Adams, D., de Almeida, M., Altucci, L., Amin, V., Amit, I., Antonarakis, S. E., Aparicio, S., Arima, T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.007 · Cited by 495
Self-citationConvergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers
Hnisz, D., Schuijers, J., Lin, C. Y., Weintraub, A. S., Abraham, B. J., Lee, T. I., Bradner, J. E., & Young, R. A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.014 · Cited by 476
AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463
Lowery, A. J., Miller, N., Devaney, A., McNeill, R. E., Davoren, P. A., Lemetre, C., Benes, V., Schmidt, S., Blake, J., Ball, G., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2257 · Cited by 450
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice
Roberts, C. W. M., Galusha, S. A., McMenamin, M. E., Fletcher, C. D. M., & Orkin, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250492697 · Cited by 433
Maintaining cell identity: PRC2-mediated regulation of transcription and cancer
Comet, I., Riising, E. M., Leblanc, B., & Helin, K. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.83 · Cited by 432
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
Lee, R. S., Stewart, C., Carter, S. L., Ambrogio, L., Cibulskis, K., Sougnez, C., Lawrence, M. S., Auclair, D., Mora, J., Golub, T. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64400 · Cited by 428
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Cromm, P. M., & Crews, C. M. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.05.024 · Cited by 412
MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
Winters, A. C., & Bernt, K. M. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00004 · Cited by 405
The shaping and functional consequences of the microRNA landscape in breast cancer
Dvinge, H., Git, A., Gräf, S., Salmon-Divon, M., Curtis, C., Sottoriva, A., Zhao, Y., Hirst, M., Armisen, J., Miska, E. A., et al. (2013) · Nature · doi:10.1038/nature12108 · Cited by 397
Munster, P. N., Thurn, K. T., Thomas, S., Raha, P., Lacevic, M., Miller, A., Melisko, M., Ismail-Khan, R., Rugo, H., Moasser, M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.156 · Cited by 391
Ramos, P., Karnezis, A. N., Craig, D. W., Sekulic, A., Russell, M. L., Hendricks, W. P. D., Corneveaux, J. J., Barrett, M. T., Shumansky, K., Yang, Y., et al. (2014) · Nature Genetics · doi:10.1038/ng.2928 · Cited by 387
Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.-J., van Deursen, J. M. A., Harada, H., & Downing, J. R. (1998) · Blood · doi:10.1182/blood.v91.9.3134 · Cited by 372
The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation
Meyers, S., Lenny, N., & Hiebert, S. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1974 · Cited by 368
Martinez-Garcia, E., Popovic, R., Min, D.-J., Sweet, S. M. M., Thomas, P. M., Zamdborg, L., Heffner, A., Will, C., Lamy, L., Staudt, L. M., et al. (2011) · Blood · doi:10.1182/blood-2010-07-298349 · Cited by 360
Sarica, O., Ozturk, E., Demirkurek, H. C., & Uluc, F. (2013) · Breast Care · doi:10.1159/000355833 · Cited by 356
Tak, Y. G., & Farnham, P. J. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0050-4 · Cited by 356
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
Wei, Y., Lai, X., Yu, S., Chen, S., Ma, Y., Zhang, Y., Li, H., Zhu, X., Yao, L., & Zhang, J. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3037-0 · Cited by 354
Jochems, C., & Schlom, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011007 · Cited by 353
Schneppenheim, R., Frühwald, M. C., Gesk, S., Hasselblatt, M., Jeibmann, A., Kordes, U., Kreuz, M., Leuschner, I., Subero, J. I. M., Obser, T., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.01.013 · Cited by 348
Development and applications of single-cell transcriptome analysis
Tang, F., Lao, K., & Surani, M. A. (2011) · Nature Methods · doi:10.1038/nmeth.1557 · Cited by 338
Whole-genome fingerprint of the DNA methylome during human B cell differentiation
Kulis, M., Merkel, A., Heath, S., Queirós, A. C., Schuyler, R. P., Castellano, G., Beekman, R., Raineri, E., Esteve, A., Clot, G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3291 · Cited by 329
Single-cell epigenomics: powerful new methods for understanding gene regulation and cell identity
Clark, S. J., Lee, H. J., Smallwood, S. A., Kelsey, G., & Reik, W. (2016) · Genome Biology · doi:10.1186/s13059-016-0944-x · Cited by 310
Disruption of Ini1 Leads to Peri-Implantation Lethality and Tumorigenesis in Mice
Guidi, C. J., Sands, A. T., Zambrowicz, B. P., Turner, T. K., Demers, D. A., Webster, W., Smith, T. W., Imbalzano, A. N., & Jones, S. N. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3598-3603.2001 · Cited by 295
PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
Martens, J. H. A., Brinkman, A. B., Simmer, F., Francoijs, K.-J., Nebbioso, A., Ferrara, F., Altucci, L., & Stunnenberg, H. G. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.042 · Cited by 292
Self-citationDNA Methylation Dynamics of Human Hematopoietic Stem Cell Differentiation
Farlik, M., Halbritter, F., Müller, F., Choudry, F. A., Ebert, P., Klughammer, J., Farrow, S., Santoro, A., Ciaurro, V., Mathur, A., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.10.019 · Cited by 289
Walker, B. A., Wardell, C. P., Chiecchio, L., Smith, E. M., Boyd, K. D., Neri, A., Davies, F. E., Ross, F. M., & Morgan, G. J. (2011) · Blood · doi:10.1182/blood-2010-04-279539 · Cited by 267
Toska, E., Osmanbeyoglu, H. U., Castel, P., Chan, C., Hendrickson, R. C., Elkabets, M., Dickler, M. N., Scaltriti, M., Leslie, C. S., Armstrong, S. A., et al. (2017) · Science · doi:10.1126/science.aah6893 · Cited by 265
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
Jagani, Z., Mora-Blanco, E. L., Sansam, C. G., McKenna, E. S., Wilson, B., Chen, D., Klekota, J., Tamayo, P., Nguyen, P. T. L., Tolstorukov, M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2251 · Cited by 251
Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia
Villa, R., Pasini, D., Gutierrez, A., Morey, L., Occhionorelli, M., Viré, E., Nomdedeu, J. F., Jenuwein, T., Pelicci, P. G., Minucci, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.009 · Cited by 247
Cell Cycle Arrest and Repression of Cyclin D1 Transcription by INI1/hSNF5
Zhang, Z.-K., Davies, K. P., Allen, J., Zhu, L., Pestell, R. G., Zagzag, D., & Kalpana, G. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5975-5988.2002 · Cited by 233
Chen, C.-W., Koche, R. P., Sinha, A. U., Deshpande, A. J., Zhu, N., Eng, R., Doench, J. G., Xu, H., Chu, S. H., Qi, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3832 · Cited by 228
CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression
Spencer, D. H., Russler-Germain, D. A., Ketkar, S., Helton, N. M., Lamprecht, T. L., Fulton, R. S., Fronick, C. C., O’Laughlin, M., Heath, S. E., Shinawi, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.01.021 · Cited by 219
Isakoff, M. S., Sansam, C. G., Tamayo, P., Subramanian, A., Evans, J. A., Fillmore, C. M., Wang, X., Biegel, J. A., Pomeroy, S. L., Mesirov, J. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509014102 · Cited by 214
Intratumoral Heterogeneity of the Epigenome
Mazor, T., Pankov, A., Song, J. S., & Costello, J. F. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.009 · Cited by 214
Betz, B. L., Strobeck, M. W., Reisman, D. N., Knudsen, E. S., & Weissman, B. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205706 · Cited by 212
Epigenome Editing: State of the Art, Concepts, and Perspectives
Kungulovski, G., & Jeltsch, A. (2016) · Trends in Genetics · doi:10.1016/j.tig.2015.12.001 · Cited by 208
van Schooneveld, E., Wouters, M. C., Van der Auwera, I., Peeters, D. J., Wildiers, H., Van Dam, P. A., Vergote, I., Vermeulen, P. B., Dirix, L. Y., & Van Laere, S. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3127 · Cited by 191
Stirzaker, C., Zotenko, E., Song, J. Z., Qu, W., Nair, S. S., Locke, W. J., Stone, A., Armstong, N. J., Robinson, M. D., Dobrovic, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms6899 · Cited by 190
ENCODE: The human encyclopaedia
Maher, B. (2012) · Nature · doi:10.1038/489046a · Cited by 189
Torchia, J., Picard, D., Lafay-Cousin, L., Hawkins, C. E., Kim, S.-K., Letourneau, L., Ra, Y.-S., Ho, K. C., Chan, T. S. Y., Sin-Chan, P., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70114-2 · Cited by 182
Veeck, J., Ropero, S., Setien, F., Gonzalez-Suarez, E., Osorio, A., Benitez, J., Herman, J. G., & Esteller, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1010 · Cited by 176
Pan-cancer patterns of DNA methylation
Witte, T., Plass, C., & Gerhauser, C. (2014) · Genome Medicine · doi:10.1186/s13073-014-0066-6 · Cited by 175
Kaiser, M. F., Johnson, D. C., Wu, P., Walker, B. A., Brioli, A., Mirabella, F., Wardell, C. P., Melchor, L., Davies, F. E., & Morgan, G. J. (2013) · Blood · doi:10.1182/blood-2013-03-487884 · Cited by 167
Metabolic Inputs into the Epigenome
Sharma, U., & Rando, O. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.003 · Cited by 167
Wang, K., Wang, P., Shi, J., Zhu, X., He, M., Jia, X., Yang, X., Qiu, F., Jin, W., Qian, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.045 · Cited by 162
Agirre, X., Castellano, G., Pascual, M., Heath, S. C., Kulis, M., Segura, V., Bergmann, A. K., Esteve‐Codina, A., Merkel, A., Raineri, E., et al. (2015) · Genome Research · doi:10.1101/gr.180240.114 · Cited by 160
Kurozumi, S., Yamaguchi, Y., Kurosumi, M., Ohira, M., Matsumoto, H., & Horiguchi, J. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2016.89 · Cited by 159
Queirós, A. C., Villamor, N., Clot, G., Martínez‐Trillos, A., Kulis, M., Navarro, A., Penas, E. M. M., Jayne, S., Majid, A., Richter, J., et al. (2014) · Leukemia · doi:10.1038/leu.2014.252 · Cited by 158
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
Stunnenberg, H. G., & Hirst, M. (2016) · Cell · doi:10.1016/j.cell.2016.12.002 · Cited by 158
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage
Queirós, A. C., Beekman, R., Vilarrasa‐Blasi, R., Duran‐Ferrer, M., Clot, G., Merkel, A., Raineri, E., Russiñol, N., Castellano, G., Beà, S., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.014 · Cited by 150
Rendeiro, A. F., Schmidl, C., Strefford, J. C., Walewska, R., Davis, Z., Farlik, M., Oscier, D., & Bock, C. (2016) · Nature Communications · doi:10.1038/ncomms11938 · Cited by 146
Richardson, P. G. G., Hungria, V., Yoon, S., Beksaç, M., Dimopoulos, M. A., Elghandour, A., Wiktor-Jędrzejczak, W., Guenther, A., Nakorn, T. N., Siritanaratkul, N., et al. (2015) · Blood · doi:10.1182/blood-2015-09-665018 · Cited by 133
Stefánsson, Ó. A., Villanueva, A., Vidal, A., Martí, L., & Esteller, M. (2012) · Epigenetics · doi:10.4161/epi.22561 · Cited by 130
Kurmasheva, R. T., Sammons, M. C., Favours, E., Wu, J., Kurmashev, D., Cosmopoulos, K., Keilhack, H., Klaus, C. R., Houghton, P. J., & Smith, M. A. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26218 · Cited by 129
Ptasinska, A., Assi, S. A., Martinez-Soria, N., Imperato, M. R., Piper, J., Cauchy, P., Pickin, A., James, S. R., Hoogenkamp, M., Williamson, D., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.024 · Cited by 128
Rhabdoid Tumor Predisposition Syndrome
Sredni, S. T., & Tomita, T. (2014) · Pediatric and Developmental Pathology · doi:10.2350/14-07-1531-misc.1 · Cited by 127
Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal
Dey, S. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.509 · Cited by 126
Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types
Onuchic, V., Hartmaier, R. J., Boone, D. N., Samuels, M. L., Patel, R. Y., White, W., Garovic, V. D., Oesterreich, S., Roth, M. E., Lee, A. V., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.057 · Cited by 117
Musashi2 sustains the mixed-lineage leukemia–driven stem cell regulatory program
Park, S.-M., Gönen, M., Vu, L., Minuesa, G., Tivnan, P., Barlowe, T. S., Taggart, J., Lu, Y., Deering, R. P., Hacohen, N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78440 · Cited by 113
Veeck, J., Wild, P. J., Fuchs, T. J., Schüffler, P. J., Hartmann, A., Knüchel, R., & Dahl, E. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-217 · Cited by 108
Exploring regulation in tissues with eQTL networks
Fagny, M., Paulson, J. N., Kuijjer, M. L., Sonawane, A. R., Chen, C.-Y., Lopes‐Ramos, C. M., Glass, K., Quackenbush, J. F., & Platig, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707375114 · Cited by 108
Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets
Gadd, S., Sredni, S. T., Huang, C., & Perlman, E. J. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.66 · Cited by 105
Martens, J. H. A., Mandoli, A., Simmer, F., Wierenga, B., Saeed, S., Singh, A. A., Altucci, L., Vellenga, E., & Stunnenberg, H. G. (2012) · Blood · doi:10.1182/blood-2012-05-429050 · Cited by 105
Self-citationNegative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy
Śledzińska, A., Menger, L., Bergerhoff, K. F., Peggs, K. S., & Quezada, S. A. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.008 · Cited by 99
Zhao, Q., Lei, P., Zhang, X., Zheng, J., Wang, H.-Y., Zhao, J., Li, Y., Ye, M., Li, L., Wei, G., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0201-x · Cited by 95
de Rinaldis, E., Gazińska, P., Mera, A., Modrusan, Z. D., Fedorowicz, G. M., Burford, B., Gillett, C., Marra, P., Grigoriadis, A. E., Dornan, D., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-643 · Cited by 91
Chai, J., Charboneau, A. L., Betz, B. L., & Weissman, B. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1896 · Cited by 87
Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5
Mora‐Blanco, E. L., Mishina, Y. M., Tillman, E. J., Cho, Y.-J., Thom, C. S., Pomeroy, S. L., Shao, W., & Roberts, C. W. M. (2013) · Oncogene · doi:10.1038/onc.2013.37 · Cited by 83
M’hamed, I. F., Privat, M., Ponelle‐Chachuat, F., Penault-Llorca, F. M., Kénani, A., & Bignon, Y. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0239-3 · Cited by 78
Finlay-Schultz, J., Cittelly, D. M., Hendricks, P., Patel, P., Kabos, P., Jacobsen, B. M., Richer, J. K., & Sartorius, C. A. (2014) · Oncogene · doi:10.1038/onc.2014.298 · Cited by 78
5‐Hydroxymethylcytosine: a new kid on the epigenetic block?
Matarese, F., Pau, E. C. D. S., & Stunnenberg, H. G. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.95 · Cited by 78
Chimge, N., Little, G. H., Baniwal, S. K., Adisetiyo, H., Xie, Y., Zhang, T., O’Laughlin, A. E., Liu, Z. Y., Ulrich, P. R., Martin, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10751 · Cited by 78
Tomita, Y., Lee, M.-J., Lee, S., Tomita, S., Chumsri, S., Cruickshank, S., Ordentlich, P., & Trepel, J. B. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1219008 · Cited by 75
Gruhn, B., Naumann, T., Gruner, D., Walther, M., Wittig, S., Becker, S., Beck, J. F., & Sonnemann, J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.07.016 · Cited by 73
Knutson, S. K., Warholic, N. M., Johnston, L. D., Klaus, C. R., Wigle, T. J., Iwanowicz, D., Littlefield, B. A., Porter-Scott, M., Smith, J. J., Moyer, M. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111840 · Cited by 72
Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer
Cochrane, D. R., Jacobsen, B. M., Connaghan, K. D., Howe, E. N., Bain, D. L., & Richer, J. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.020 · Cited by 72
Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune Systems
Schuyler, R. P., Merkel, A., Raineri, E., Altucci, L., Vellenga, E., Martens, J. H. A., Pourfarzad, F., Kuijpers, T. W., Burden, F., Farrow, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.054 · Cited by 71
Self-citationmiR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
He, Y., WU, J.-Z., Ji, M., Ma, T., Qiao, E., Ma, R., & Tang, J. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.915 · Cited by 70
Quantitative Analysis of Micrornas in Tissue Microarrays by in Situ Hybridization
Hanna, J. A., Wimberly, H., Kumar, S., Slack, F. J., Agarwal, S., & Rimm, D. L. (2012) · BioTechniques · doi:10.2144/000113837 · Cited by 69
Mandoli, A., Singh, A. A., Prange, K. H. M., Tijchon, E. J. H., Oerlemans, M. M. P., Dirks, R. A. M., ter Huurne, M., Wierenga, A. T. J., Janssen‐Megens, E. M., Berentsen, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.082 · Cited by 64
Self-citationHealey, M. A., Hu, R., Beck, A. H., Collins, L. C., Schnitt, S. J., Tamimi, R. M., & Hazra, A. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3089-1 · Cited by 62
Tonks, A. J., Tonks, A. J., Pearn, L., Pearce, L., Hoy, T. G., Couzens, S., Fisher, J., Burnett, A. K., & Darley, R. L. (2004) · Leukemia · doi:10.1038/sj.leu.2403396 · Cited by 58
Mathe, A., Wong‐Brown, M. W., Locke, W. J., Stirzaker, C., Braye, S. G., Forbes, J., Clark, S. J., Avery‐Kiejda, K. A., & Scott, R. J. (2016) · Scientific Reports · doi:10.1038/srep33435 · Cited by 57
Jerónimo, C., Monteiro, P., Henrique, R., Dinis-Ribeiro, M. J., Costa, I., Costa, V. L., Filipe, L., Carvalho, A. L., Hoque, M. O., Pais, I., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9620-x · Cited by 55
Moreaux, J., Reme, T. X., Leonard, W., Veyrune, J., Requirand, G., Goldschmidt, H., Hose, D., & Klein, B. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0721 · Cited by 55
Epigenetic drugs: from chemistry via biology to medicine and back
Altucci, L., & Rots, M. G. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0222-5 · Cited by 53
Self-citationProject set to map marks on genome
Abbott, A. (2010) · Nature · doi:10.1038/463596b · Cited by 51
p16INK4Aand p14ARFTumor Suppressor Pathways Are Deregulated in Malignant Rhabdoid Tumors
Venneti, S., Le, P., Martínez, D., Eaton, K. W., Shyam, N., Jordan‐Sciutto, K. L., Pawel, B., Biegel, J. A., & Judkins, A. R. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822146ca · Cited by 50
Hypermethylated Genes as Biomarkers of Cancer in Women with Pathologic Nipple Discharge
Fackler, M. J., Rivers, A., Teo, W. W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1981 · Cited by 49
Epigenome data release: a participant-centered approach to privacy protection
Dyke, S. O. M., Cheung, W., Joly, Y., Ammerpohl, O., Lutsik, P., Rothstein, M. A., Caron, M., Busche, S., Bourque, G., Rönnblom, L., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0723-0 · Cited by 43
High-intensity UV laser ChIP-seq for the study of protein-DNA interactions in living cells
Steube, A., Schenk, T., Tretyakov, A. N., & Saluz, H. P. (2017) · Nature Communications · doi:10.1038/s41467-017-01251-7 · Cited by 41
High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia
Mu, Q., Wang, Y., Chen, B., Qian, W., Meng, H., Tong, H., Chen, F., Ma, Q., Ni, W., Chen, S., et al. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.05.012 · Cited by 39
Li, M. J., Liu, Z., Liu, Z., Yan, B., Pan, Z., Huang, D., Liang, Q., Ying, D., Xu, F., Yao, H., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1177-3 · Cited by 36
The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
Karslı-Çeppioğlu, S., Dagdemir, A., Judes, G., Lebert, A., Penault-Llorca, F. M., Bignon, Y., & Bernard-Gallon, D. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-06790-z · Cited by 36
Cesuroğlu, T., Syurina, E. V., FERON, F. J. M., & Krumeich, A. J. S. M. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010243 · Cited by 33
Molecular Pathways: The Complexity of the Epigenome in Cancer and Recent Clinical Advances
Conte, M., & Altucci, L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2037 · Cited by 32
Self-citationH3K4 Acetylation, H3K9 Acetylation and H3K27 Methylation in Breast Tumor Molecular Subtypes
Judes, G., Dagdemir, A., Karslı-Çeppioğlu, S., Lebert, A., Echegut, M., Ngollo, M., Bignon, Y., Penault-Llorca, F. M., & Bernard-Gallon, D. J. (2016) · Epigenomics · doi:10.2217/epi-2016-0015 · Cited by 31
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies
Fratta, E., Montico, B., Rizzo, A., Colizzi, F., Sigalotti, L., & Dolcetti, R. (2016) · Oncotarget · doi:10.18632/oncotarget.10033 · Cited by 26
Singh, A. A., Mandoli, A., Prange, K. H. M., Laakso, M., & Martens, J. H. A. (2016) · Oncotarget · doi:10.18632/oncotarget.14150 · Cited by 26
Buchi, F., Masala, E., Rossi, A., Valencia, A., Spinelli, E., Sanna, A., Gozzini, A., & Santini, V. (2013) · Epigenetics · doi:10.4161/epi.27322 · Cited by 24
Bergmann, A. K., Castellano, G., Alten, J., Ammerpohl, O., Kolarova, J., Nordlund, J., Martín-Subero, J. I., Schrappe, M., & Siebert, R. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26251 · Cited by 23
Perspectives and future directions for epigenetics in hematology
Goodell, M. A., & Godley, L. A. (2013) · Blood · doi:10.1182/blood-2013-04-427724 · Cited by 22
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses
Nebbioso, A., Benedetti, R., Conte, M., Carafa, V., Bellis, F. D., Shaik, J., Matarese, F., Ventura, B. D., Gesuele, F., Velotta, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12010-5 · Cited by 16
Self-citation
Cited by
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Molecular profiling for precision cancer therapies
Malone, E. R., Oliva, M., Sabatini, P. J. B., Stockley, T. L., & Siu, L. L. (2020) · Genome Medicine · doi:10.1186/s13073-019-0703-1 · Cited by 913
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Lee, S., Rauch, J., & Kolch, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031102 · Cited by 799
Metabolism of Amino Acids in Cancer
Wei, Z., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 429
Anticancer drug resistance: An update and perspective
Nussinov, R., Tsai, C.-J., & Jang, H. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100796 · Cited by 386
Metadata
- Authors
- Nebbioso, A., Tambaro, F. P., Dell’Aversana, C., & Altucci, L.
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-06-07
- Volume
- 14
- Issue
- 6
- Pages
- e1007362
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W2805162488
- Cited by
- 480
- References
- 148
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.